Aquarius Invest

Aquarius Invest GmbH is a German investment firm focusing on early-stage companies at the intersection of health, innovation, digitalization, and sustainability. The firm is managed by Dr. Christoph Labisch, who leverages his background in medicine, business administration, and artificial intelligence to evaluate and support startups. Dr. Labisch has extensive experience in the healthcare sector, including roles as a managing partner at a radiology center and as an innovations manager, where he focused on implementing new business ideas, including AI-based solutions.

The company's investment strategy centers on MedTech startups working on telemedicine, wearable devices, robotics, and AI-based diagnostic tools. Aquarius Invest provides more than just capital; it offers access to a broad network within the medical community, aiming to enhance the credibility of its portfolio companies and facilitate partnerships and pilot projects. The firm's approach is patient-centric, ensuring that the innovations it backs are practical and clinically relevant. Additionally, Aquarius Invest supports companies developing environmentally friendly medical technologies and digital health solutions to reduce the ecological footprint of the healthcare industry.

The portfolio includes companies like Gleamer, which uses AI for radiological image analysis; EasyRadiology, a provider of digital solutions for radiological imaging and reporting; and Detechgene, which is developing a rapid gene test to identify pathogens.

Keywords: MedTech investor, healthcare startups, digital health, sustainability investment, medical technology, AI in healthcare, early-stage venture capital, telemedicine, medical imaging, radiology innovation, digital pathology, healthcare digitalization, German VC, clinical relevance, robotics in medicine, wearable technology, diagnostic tools, patient-centered innovation, healthcare network, pilot projects